Scientists hunt for clues in old cancer samples to predict treatment failure
NCT ID NCT07387861
Summary
This study aims to understand why some breast cancers stop responding to standard hormone therapy. Researchers will analyze stored tumor tissue from 70 patients who previously received treatment, looking for specific protein patterns. The goal is to find markers that might predict which cancers become resistant to therapy, potentially guiding future treatment decisions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER - ER+, HER2-, PIK3CA GENE MUTATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.